High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
Saved in:
| Title: | High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM. |
|---|---|
| Authors: | Kelaidi, C.1, Beyne-Rauzy, O.1, Braun, T.1, Sapena, R.1, Cougoul, P.1, Adès, L.1, Pillard, F.1, Lambert, C.1, Charniot, J.1, Guerci, A.1, Choufi, B.1, Stamatoullas, A.1, Slama, B.1, Renzis, B.1, Ame, S.1, Damaj, G.1, Boyer, F.1, Chaury, M.1, Legros, L.1, Cheze, S.1 |
| Source: | Annals of Hematology. May2013, Vol. 92 Issue 5, p621-631. 11p. 1 Diagram, 3 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
